Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biological markers in depression.

W E Bunney, B Garland-Bunney, S B Patel

    Psychopathology
    |January 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    This review explores biological markers for diagnosing and treating affective disorders. Promising markers like 5-HIAA and melatonin aid in predicting relapse and suicide risk.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Efficient extraction of cucurbitacins from Diplocyclos palmatus (L.) C. Jeffrey: Optimization using response surface methodology, extraction methods and study of some important bioactivities.

    Scientific reports·2020
    Same author

    Electrophysiological evaluation of extracellular spermine and alkaline pH on synaptic human GABA<sub>A</sub> receptors.

    Translational psychiatry·2019
    Same author

    Quantitative validation of immunofluorescence and lectin staining using reduced CLARITY acrylamide formulations.

    Brain structure & function·2017
    Same author

    Variable telomere length across post-mortem human brain regions and specific reduction in the hippocampus of major depressive disorder.

    Translational psychiatry·2016
    Same author

    The Effects of Altitude, Temperature, Gas to Sclerosant Ratio, Air Versus 50:50 Mixture of CO2 and O2, Foam Volume, Presence of Silicone, and Consecutive Uses of Syringes on the Longevity of Tessari-Made Foam for Sclerotherapy.

    Journal of vascular surgery. Venous and lymphatic disorders·2016
    Same author

    Functional brain imaging, sleep, and sleep deprivation: contributions to the "overarousal" hypothesis of depression.

    Acta neuropsychiatrica·2016
    Same journal

    Depersonalization, Emotion Embodiment, and Alexithymia in the General Population.

    Psychopathology·2026
    Same journal

    Symptom course in psychiatric and neurodevelopmental diagnostic reasoning: an exploratory vignette-based study.

    Psychopathology·2026
    Same journal

    Operationalizing the Whole of Psychic Life: Toward a Structured Framework for Psychopathology.

    Psychopathology·2026
    Same journal

    From Subjective Impression to Objective Measure: The Nonverbal Foundations of the Praecox Feeling.

    Psychopathology·2026
    Same journal

    Empirical Phenomenological Psychopathology: Aims, methods, and explanatory relevance.

    Psychopathology·2026
    Same journal

    Decreased Sound Tolerance in Autism: A Clinical-Phenomenological Study.

    Psychopathology·2026
    See all related articles

    Area of Science:

    • Neuroscience
    • Psychiatry
    • Genetics

    Background:

    • Affective illnesses represent a significant global health burden.
    • Accurate diagnosis and treatment selection remain challenging.
    • Biological markers offer potential for objective assessment.

    Purpose of the Study:

    • To review existing and potential biological markers for affective disorders.
    • To discuss the utility of markers in diagnosis, treatment selection, and prognosis.
    • To explore novel strategies for marker discovery.

    Main Methods:

    • Literature review of studies on biological markers in affective illness.
    • Discussion of specific candidate markers: 5-HIAA, 3H-imipramine platelet binding, REM induction, melatonin.
    • Presentation of gene mapping as a marker detection strategy.

    Related Experiment Videos

    Main Results:

    • Several promising biological markers are identified for affective disorders.
    • Markers show potential for aiding diagnosis, medication selection, and predicting relapse/suicide.
    • Combinatorial marker use and application during well-states may enhance accuracy.

    Conclusions:

    • Biological markers hold significant promise for advancing the study and treatment of affective illness.
    • Further research is needed to validate and integrate these markers into clinical practice.
    • Gene mapping offers a pathway to discovering new, powerful diagnostic and prognostic markers.